The industry needs credibility with consumers to make a spoonful of risk go down. So how does pharma speak to top concerns?
Margaret Mueller, Leo J. Shapiro & Associates
Advertisement
Margaret Mueller, Leo J. Shapiro & Associates
Articles by Margaret Mueller, Leo J. Shapiro & Associates
Advertisement
Latest Updated Articles
Earning the Public Trust—and Keeping ItPublished: March 1st 2008 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Single-Injection, Once-Monthly Maintenance Regimen for Lilly’s Omvoh in Ulcerative Colitis
2
What Impact will DTC Programs have on Generic Drug Prices?
3
Organon CEO Kevin Ali to Resign Following Internal Investigation into Nexplanon Sales
4
GSK Enters $745 Million Worldwide Exclusive License Agreement with Empirico for Clinical-Stage First-In-Class Oligonucleotide Candidate
5
